Loteprednol Etabonate
Also known as: Alrex, Eysuvis, Inveltys, Lotemax, Lotemax Sm, Loteprednol.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 0.2% | Drops | $30.60 / mL | Generic |
| 0.25% | Drops | $61.59 / mL | Brand |
| 0.38% | Gel | $49.48 / gram | Brand |
| 0.5% | Ointment | $99.76 / gram | Brand |
| 0.5% | Gel | $14.27 / gram | Generic |
| 0.5% | Drops | $17.92 / mL | Generic |
| 1% | Drops | $103.20 / mL | Brand |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates. Liquids, creams, and sprays are priced per mL or gram; a typical package may be a bottle or tube (size not set yet).
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $9,757,594 gross for Loteprednol Etabonate across 27,519 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$33,976,068 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS